Kodiak Sciences Inc. (KOD)
NASDAQ$3.64
Market Cap
$191.55M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
667 of 924
Rank in Industry
379 of 527
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
KOD Insider Trading Activity
KOD Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $12,453 | 2 | 100 |
Related Transactions
| BORGESON JOHN A. | See Remarks | 0 | $0 | 2 | $12,453 | $-12,453 |
About Kodiak Sciences Inc.
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate …
Insider Activity of Kodiak Sciences Inc.
Over the last 12 months, insiders at Kodiak Sciences Inc. have bought $0 and sold $12,453 worth of Kodiak Sciences Inc. stock.
On average, over the past 5 years, insiders at Kodiak Sciences Inc. have bought $114.81M and sold $7.31M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 13,155 shares for transaction amount of $104,363 was made by BAKER FELIX () on 2022‑06‑02.
List of Insider Buy and Sell Transactions, Kodiak Sciences Inc.
| 2024-06-17 | Sale | BORGESON JOHN A. | See Remarks | 2,874 0.0053% | $2.75 | $7,904 | +35.69% | |
| 2024-06-12 | Sale | BORGESON JOHN A. | See Remarks | 1,558 0.0031% | $2.92 | $4,549 | +30.65% | |
| 2023-06-16 | Sale | BORGESON JOHN A. | See Remarks | 2,749 0.0054% | $9.23 | $25,373 | -64.78% | |
| 2023-06-16 | Sale | EHRLICH JASON | See Remarks | 2,258 0.0044% | $9.23 | $20,841 | -64.78% | |
| 2023-06-14 | Sale | BORGESON JOHN A. | See Remarks | 1,448 0.0029% | $9.42 | $13,640 | -64.84% | |
| 2023-06-14 | Sale | EHRLICH JASON | See Remarks | 1,132 0.0023% | $9.42 | $10,663 | -64.84% | |
| 2022-06-15 | Sale | BORGESON JOHN A. | See Remarks | 2,798 0.0053% | $7.02 | $19,642 | +3.65% | |
| 2022-06-15 | Sale | EHRLICH JASON | See Remarks | 2,282 0.0043% | $7.02 | $16,020 | +3.65% | |
| 2022-06-02 | BAKER FELIX | 13,155 0.0255% | $7.93 | $104,363 | -6.75% | |||
| 2022-05-25 | BAKER FELIX | 116 0.0002% | $6.75 | $784 | +10.48% | |||
| 2022-05-16 | BAKER FELIX | 8,118 0.0163% | $5.99 | $48,599 | +29.47% | |||
| 2022-02-25 | Sale | PERLROTH VICTOR | Chairman and CEO | 340,000 0.6641% | $8.99 | $3.06M | -12.81% | |
| 2022-02-24 | Sale | PERLROTH VICTOR | Chairman and CEO | 1M 1.9233% | $9.20 | $9.2M | -16.03% | |
| 2022-02-17 | BAKER BROS. ADVISORS LP | 300,000 0.5801% | $54.56 | $16.37M | -28.56% | |||
| 2022-02-16 | BAKER BROS. ADVISORS LP | 95,165 0.1782% | $54.12 | $5.15M | -30.14% | |||
| 2022-02-15 | BAKER BROS. ADVISORS LP | 5,800 0.0107% | $54.16 | $314,099 | -31.11% | |||
| 2022-01-31 | BAKER BROS. ADVISORS LP | 30,148 0.0563% | $57.22 | $1.73M | -32.88% | |||
| 2022-01-28 | BAKER BROS. ADVISORS LP | 55,258 0.0977% | $50.42 | $2.79M | -27.90% | |||
| 2022-01-27 | BAKER BROS. ADVISORS LP | 262,259 0.5015% | $51.76 | $13.57M | -24.08% | |||
| 2022-01-25 | BAKER BROS. ADVISORS LP | 5,500 0.0104% | $58.90 | $323,934 | -34.11% |
Total: 91
*Gray background shows transactions not older than one year
Insider Historical Profitability
11.85%
| BAKER FELIX | 15617369 29.6774% | $56.85M | 3 | 0 | +11.07% | |
| BAKER BROS. ADVISORS LP | 14734965 28.0006% | $53.64M | 41 | 0 | +11.65% | |
| PROFUSEK ROBERT | director | 10000 0.019% | $36,400.00 | 1 | 0 | <0.0001% |
| Levy Richard S | director | 1000 0.0019% | $3,640.00 | 1 | 0 | +41% |
Historical Insider Profitability vs. Competitors
$7,150,333 | 87 | -8.28% | $207.01M | |
Kodiak Sciences Inc. (KOD) | $613,304,943 | 46 | 11.85% | $191.55M |
$48,218,096 | 42 | 0.89% | $204.72M | |
$63,049,419 | 31 | 2.87% | $207.33M | |
$41,069,367 | 23 | 54.64% | $211.17M |
KOD Institutional Investors: Active Positions
| Increased Positions | 53 | +47.75% | 6M | +16.4% |
| Decreased Positions | 44 | -39.64% | 4M | -9.78% |
| New Positions | 22 | New | 3M | New |
| Sold Out Positions | 14 | Sold Out | 2M | Sold Out |
| Total Postitions | 120 | +8.11% | 42M | +6.62% |
KOD Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Baker Bros. Advisors Lp | $71,146.00 | 32.66% | 17.31M | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $15,320.00 | 7.03% | 3.73M | -210,401 | -5.34% | 2024-12-31 |
| Vanguard Group Inc | $6,914.00 | 3.17% | 1.68M | -2,920 | -0.17% | 2024-12-31 |
| Acadian Asset Management Llc | $6,298.00 | 2.89% | 1.53M | -421,885 | -21.59% | 2024-12-31 |
| Price T Rowe Associates Inc /Md/ | $5,214.00 | 2.39% | 1.27M | +1M | +10,982.55% | 2024-12-31 |
| Tcg Crossover Management, Llc | $4,708.00 | 2.16% | 1.15M | +137,380 | +13.63% | 2024-12-31 |
| Adage Capital Partners Gp, L.L.C. | $4,683.00 | 2.15% | 1.14M | +1M | New | 2024-12-31 |
| Iconiq Capital, Llc | $4,179.00 | 1.92% | 1.02M | 0 | 0% | 2024-12-31 |
| Boxer Capital Management, Llc | $4,110.00 | 1.89% | 1M | +1M | New | 2024-12-31 |
| Silverarc Capital Management, Llc | $4,110.00 | 1.89% | 1M | +500,000 | New | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.